(Q44037735)

English

A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity

scientific article

Statements

A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity (English)
27 August 2014

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit